Howard Mayer
Direktor/Vorstandsmitglied bei PEPGEN INC.
Aktive Positionen von Howard Mayer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PEPGEN INC. | Direktor/Vorstandsmitglied | 15.11.2023 | - |
Melmark Charitable Foundation
 Melmark Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Melmark Charitable Foundation manages and coordinates all fundraising efforts throughout the Melmark organization. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
Autism Speaks, Inc.
 Autism Speaks, Inc. Miscellaneous Commercial ServicesCommercial Services Autism Speaks, Inc. is an organization dedicated to advocating for individuals with autism spectrum disorder and their families. The non-profit company is based in New York, NY. The company aims to increase understanding and acceptance of people with autism and advance research into better interventions for autism spectrum disorder and related conditions. The company was founded by Robert C. Wright and Keith Andrew Wargo has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | - |
Karriereverlauf von Howard Mayer
Ehemalige bekannte Positionen von Howard Mayer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IPSEN | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2019 | 22.09.2023 |
| Ipsen Biopharmaceuticals, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2019 | 01.09.2023 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 05.08.2019 | 01.07.2022 |
| Independent Dir/Board Member | 05.08.2019 | 01.07.2022 | |
| INVIVYD, INC. | Direktor/Vorstandsmitglied | 24.08.2020 | 24.06.2022 |
| Independent Dir/Board Member | 24.08.2020 | 24.06.2022 | |
| GENOCEA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.03.2017 | 03.08.2020 |
| Independent Dir/Board Member | 06.03.2017 | 03.08.2020 | |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Howard Mayer
| University of Pennsylvania | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 16 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 6 |
| Director/Board Member | 6 |
| Independent Dir/Board Member | 3 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| PFIZER, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| IPSEN | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INVIVYD, INC. | Health Technology |
| PEPGEN INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Melmark Charitable Foundation
Melmark Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Melmark Charitable Foundation manages and coordinates all fundraising efforts throughout the Melmark organization. | Miscellaneous |
Autism Speaks, Inc.
Autism Speaks, Inc. Miscellaneous Commercial ServicesCommercial Services Autism Speaks, Inc. is an organization dedicated to advocating for individuals with autism spectrum disorder and their families. The non-profit company is based in New York, NY. The company aims to increase understanding and acceptance of people with autism and advance research into better interventions for autism spectrum disorder and related conditions. The company was founded by Robert C. Wright and Keith Andrew Wargo has been the CEO of the company since 2021. | Commercial Services |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| Ipsen Biopharmaceuticals, Inc. |
- Börse
- Insiders
- Howard Mayer
- Erfahrung
